TheraMAB LLC
- Country
- 🇷🇺Russia
- Ownership
- Holding
- Established
- 2000-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.theramab.ru
Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Dose Escalation Study of TAB08 in Patients With Advanced Solid Neoplasms
- First Posted Date
- 2016-12-30
- Last Posted Date
- 2021-10-06
- Lead Sponsor
- Theramab LLC
- Target Recruit Count
- 12
- Registration Number
- NCT03006029
- Locations
- 🇷🇺
GBU Ryazanskoy Oblasti "Oblastnoy klinicheckiy oncologicheskiy dispanser", Ryazan', Russian Federation
TAB08 in Patients With Psoriasis Vulgaris, Not Adequately Controlled With Current Treatment
- First Posted Date
- 2016-06-10
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- Theramab LLC
- Target Recruit Count
- 9
- Registration Number
- NCT02796053
- Locations
- 🇷🇺
Clinical Emergency Hospital of Yaroslavl, Yaroslavl, Russian Federation
TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment
- First Posted Date
- 2016-03-17
- Last Posted Date
- 2018-05-23
- Lead Sponsor
- Theramab LLC
- Target Recruit Count
- 60
- Registration Number
- NCT02711813
- Locations
- 🇷🇺
Federal State Budget Institution "Research Institute of Rheumatology of V.A. Nasonova" Russian Academy of Medical Sciences, Moscow, Russian Federation
Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis
- First Posted Date
- 2013-11-21
- Last Posted Date
- 2017-02-28
- Lead Sponsor
- Theramab LLC
- Target Recruit Count
- 18
- Registration Number
- NCT01990157
- Locations
- 🇷🇺
State Scientific and Research Rheumatology Institute, Moscow, Russian Federation
🇷🇺Clinical Emergency Hospital of Yaroslavl, Yaroslavl, Russian Federation
Open Label Phase 1 Pharmacokinetics and Tolerability Study of Single TAB08 Administration in Healthy Volunteers
- Conditions
- Adult Healthy Volunteers
- First Posted Date
- 2013-06-25
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- Theramab LLC
- Target Recruit Count
- 31
- Registration Number
- NCT01885624
- Locations
- 🇷🇺
Clinical Emergency Hospital of Yaroslavl, Yaroslavl, Russian Federation